Lilly’s daily-pill GLP-1 Foundayo wins EMA backing for EU weight-loss and diabetes use

Eli Lilly’s oral GLP-1 treatment Foundayo has received a positive recommendation from the European Medicines Agency, bringing it closer to EU approval for weight management and type 2 diabetes. The European Medicines Agency’s medicines committee has backed Eli Lilly’s oral…















